2500 INNOVATION WAY, GREENFIELD, IN
Reports Second Quarter 2025 Results
News, Material Contracts
Appoints Robert (Bob) VanHimbergen as Chief Financial Officer
Shareholder votes
Reports First Quarter 2025 Results
Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets
Earnings Release
Investor Presentation
Q2
Q1
FY 2023
Q3
Registration Statement for Securities to be Offered to Employees
Certificate
Registration of Securities
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Definitive Additional Information Statement
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report